Correlia Biosystems
InactiveNext-gen blood testing to provide 1000x more data to pharma companies
What it does
Correlia Biosystems is a UC Berkeley spinoff company based in Berkeley, CA. Correlia develops innovative microscale tools that accelerate rapid quantification of biomolecules. Our versatile "SimpleScan" technology opens up new biological questions from one microliter of sample, with rapid results that allow for dynamic monitoring of protein expression profiles (rather than simple end-point measurement). Applications range from enabling next-gen proteomic data sets to point-of-care diagnostics.
Next to it in Healthcare and bio · Microscale blood testing hardware for pharma
- InnaMedY Combinator W17
At-home blood testing: measure + analyze + enhance.
- Clip HealthY Combinator S16
Testing & treatment at home, in minutes, for chronic & acute disease
- RizLab HealthSOSV SOSV IndieBio NY 03
Bringing blood analysis to patients' fingertips
- 株式会社新日本科学Plug and Play
Shin Nippon Biomedical Laboratories (SNBL), was founded in Kagoshima as Japan’s first contract research organization in 1957.
- DeleeY Combinator W17
Blood testing device for early diagnosis of cancer and treatment…
- LSK TechnologiesY Combinator S20
A diagnostic lab in a box
- Vena VitalsY Combinator S20
A small sticker that monitors blood pressure continuously
- Indee LabsSOSV SOSV IndieBio 02
Developing scalable hardware for gene delivery